Page 57 - Read Online

Zhang et al. Vessel Plus 2021;5:48 https://dx.doi.org/10.20517/2574-1209.2021.64 Page 11 of 14

departure by ESHRE. European Society for Human Reproduction and Embryology. Hum Reprod 1996;11:1776-7. DOI PubMed
77. Yasumizu K, Kato J. Introduction to obstetrical endocrinology. 23. Sex differentiation and hormones. Josanpu Zasshi 1985;39:168-
73. (in Japanese). PubMed
78. Karteris E, Zervou S, Pang Y, et al. Progesterone signaling in human myometrium through two novel membrane G protein-coupled
receptors: potential role in functional progesterone withdrawal at term. Mol Endocrinol 2006;20:1519-34. DOI PubMed
79. Tokumoto T, Tokumoto M, Oshima T, et al. Characterization of multiple membrane progestin receptor (mPR) subtypes from the
goldfish ovary and their roles in the induction of oocyte maturation. Gen Comp Endocrinol 2012;177:168-76. DOI PubMed
80. Tokumoto T, Hossain MB, Wang J. Establishment of procedures for studying mPR-interacting agents and physiological roles of
mPR. Steroids 2016;111:79-83. DOI PubMed
81. Jiang C, Zuo F, Wang Y, et al. Progesterone exerts neuroprotective effects and improves long-term neurologic outcome after
intracerebral hemorrhage in middle-aged mice. Neurobiol Aging 2016;42:13-24. DOI PubMed PMC
82. Simoncini T, Mannella P, Fornari L, et al. Differential signal transduction of progesterone and medroxyprogesterone acetate in
human endothelial cells. Endocrinology 2004;145:5745-56. DOI PubMed
83. Dosiou C, Hamilton AE, Pang Y, et al. Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells
and activation of G-proteins by progesterone. J Endocrinol 2008;196:67-77. DOI PubMed
84. Pang Y, Thomas P. Progesterone signals through membrane progesterone receptors (mPRs) in MDA-MB-468 and mPR-transfected
MDA-MB-231 breast cancer cells which lack full-length and N-terminally truncated isoforms of the nuclear progesterone receptor.
Steroids 2011;76:921-8. DOI PubMed PMC
85. Sleiter N, Pang Y, Park C, et al. Progesterone receptor A (PRA) and PRB-independent effects of progesterone on gonadotropin-
releasing hormone release. Endocrinology 2009;150:3833-44. DOI PubMed PMC
86. Zuo L, Li W, You S. Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane
progesterone receptor mediated pathway. Breast Cancer Res 2010;12:R34. DOI PubMed PMC
87. Dressing GE, Lange CA. Integrated actions of progesterone receptor and cell cycle machinery regulate breast cancer cell
proliferation. Steroids 2009;74:573-6. DOI PubMed PMC
88. Dressing GE, Thomas P. Identification of membrane progestin receptors in human breast cancer cell lines and biopsies and their
potential involvement in breast cancer. Steroids 2007;72:111-6. DOI PubMed
89. Adam PJ, Boyd R, Tyson KL, et al. Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with
potential roles in clinical cancer. J Biol Chem 2003;278:6482-9. DOI PubMed
90. Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature 2012;490:61-70. DOI PubMed PMC
91. Castelnovo LF, Magnaghi V, Thomas P. Expression of membrane progesterone receptors (mPRs) in rat peripheral glial cell
membranes and their potential role in the modulation of cell migration and protein expression. Steroids 2019;142:6-13. DOI
PubMed
92. Charles NJ, Thomas P, Lange CA. Expression of membrane progesterone receptors (mPR/PAQR) in ovarian cancer cells:
implications for progesterone-induced signaling events. Horm Cancer 2010;1:167-76. DOI PubMed PMC
93. Dressing GE, Alyea R, Pang Y, Thomas P. Membrane progesterone receptors (mPRs) mediate progestin induced antimorbidity in
breast cancer cells and are expressed in human breast tumors. Horm Cancer 2012;3:101-12. DOI PubMed
94. Jiang G, Zhang S, Yazdanparast A, et al. Comprehensive comparison of molecular portraits between cell lines and tumors in breast
cancer. BMC Genomics 2016;17 Suppl 7:525. DOI PubMed PMC
95. Zhao Y, Ruan X, Wang H, et al. The presence of a membrane-bound progesterone receptor induces growth of breast cancer with
norethisterone but not with progesterone: a xenograft model. Maturitas 2017;102:26-33. DOI
96. Abou-Fadel J, Grajeda B, Jiang X, et al. CmP signaling network unveils novel biomarkers for triple negative breast cancer in African
American women. bioRxiv 2021. DOI
97. Thomas P, Pang Y. Membrane progesterone receptors: evidence for neuroprotective, neurosteroid signaling and neuroendocrine
functions in neuronal cells. Neuroendocrinology 2012;96:162-71. DOI PubMed PMC
98. Nutu M, Weijdegård B, Thomas P, Thurin-Kjellberg A, Billig H, Larsson DG. Distribution and hormonal regulation of membrane
progesterone receptors beta and gamma in ciliated epithelial cells of mouse and human fallopian tubes. Reprod Biol Endocrinol
2009;7:89. DOI PubMed PMC
99. Canavero S. Intramedullary cavernous angiomas of the spinal cord: clinical presentation, pathological features, and surgical
management. Neurosurgery 1993;32:692-3. DOI PubMed
100. Ogilvy CS, Louis DN, Ojemann RG. Intramedullary cavernous angiomas of the spinal cord: clinical presentation, pathological
features, and surgical management. Neurosurgery 1992;31:219-29; discussion 229. DOI PubMed
101. Burkhardt JK, Bozinov O, Nürnberg J, et al. Neurosurgical considerations on highly eloquent brainstem cavernomas during
pregnancy. Clin Neurol Neurosurg 2012;114:1172-6. DOI PubMed
102. Aiba T, Tanaka R, Koike T, Kameyama S, Takeda N, Komata T. Natural history of intracranial cavernous malformations. J
Neurosurg 1995;83:56-9. DOI PubMed
103. Awada A, Watson T, Obeid T. Cavernous angioma presenting as pregnancy-related seizures. Epilepsia 1997;38:844-6. DOI
PubMed
104. Porter RW, Detwiler PW, Spetzler RF, et al. Cavernous malformations of the brainstem: experience with 100 patients. J Neurosurg
1999;90:50-8. DOI PubMed
105. Gross BA, Lin N, Du R, Day AL. The natural history of intracranial cavernous malformations. Neurosurg Focus 2011;30:E24. DOI
PubMed